Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S ADR
(NY:
NVO
)
141.96
+0.97 (+0.69%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,033,305
Open
141.46
Bid (Size)
141.55 (1)
Ask (Size)
142.00 (1)
Prev. Close
140.99
Today's Range
141.21 - 142.56
52wk Range
75.56 - 144.50
Shares Outstanding
N/A
Dividend Yield
1.25%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Biotech Stocks to Buy Now: June 2024
June 21, 2024
These are the three best biotech stocks to buy for long-term returns and portfolio stability due to their target patient populations,
Via
InvestorPlace
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Gilead Sciences faces Wall Street speculation about its potential in the obesity drug market despite its focus on liver treatments.
Via
Benzinga
Performance
YTD
+39.03%
+39.03%
1 Month
+4.71%
+4.71%
3 Month
+10.00%
+10.00%
6 Month
+38.25%
+38.25%
1 Year
+78.49%
+78.49%
More News
Read More
Lawsuit Could Challenge Trust In Ozempic And Other Popular Weight Loss Drugs
June 21, 2024
Via
Talk Markets
Topics
Lawsuit
Exposures
Financial
Legal
The Best Could Be Yet to Come for Novo Nordisk and Ozempic
June 21, 2024
Via
The Motley Fool
Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
June 21, 2024
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $600 Today
June 14, 2024
Via
Benzinga
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
June 21, 2024
Via
Benzinga
German Drug Developer Evotec Seeks Adviser Input As Takeover Concerns Mount
June 20, 2024
Via
Benzinga
Eli Lilly Expands Fight Against Counterfeit Obesity Drug Zepbound With New Legal Actions
June 20, 2024
Via
Benzinga
7 Stocks With Impressive Earnings Growth: Real or Engineered?
June 19, 2024
Via
InvestorPlace
Eli Lilly Hits All-Time High, Named To Big Cap 20 List: Check These Lists For Best Stocks To Buy
June 18, 2024
Via
Investor's Business Daily
3 Mega Cap Stock Bargains As Markets Hit All-Time Highs
June 18, 2024
Via
Benzinga
Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment, Though Novo Nordisk's Drug Still Sees Strong Demand
June 18, 2024
Via
Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
June 18, 2024
Via
The Motley Fool
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
June 17, 2024
Via
Investor's Business Daily
Could Structure Therapeutics Become the Next Novo Nordisk?
June 17, 2024
Via
The Motley Fool
3 Best Stocks to Buy From the Fantastic 5
June 17, 2024
Via
InvestorPlace
Week Of June 16: What's In Store For The Markets
June 16, 2024
Via
Talk Markets
Where Will Madrigal Pharmaceuticals Be in 3 Years?
June 15, 2024
Via
The Motley Fool
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
June 15, 2024
Via
The Motley Fool
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
June 14, 2024
Via
Investor's Business Daily
7 A-Rated Biotech Stocks Worth Betting on in June
June 14, 2024
Via
InvestorPlace
3 Stocks to Sell as Ozempic Surges in Popularity
June 14, 2024
Via
InvestorPlace
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
June 14, 2024
Via
The Motley Fool
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity Drug
June 14, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.